Antilymphocyte immunoglobulin (horse) Completed Phase 2 Trials for Childhood Chronic Myelogenous Leukemia / previously treated Myelodysplastic Syndromes (MDS) / primary Myelodysplastic Syndromes (MDS) / Adult Acute Myeloid Leukemia With T(16;16)(p13;q22) / Adult Acute Myeloid Leukemia With T(8;21)(q22;q22) / Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities / Recurrent Adult Acute Myeloid Leukemia / Childhood Myelodysplastic Syndromes / Adult Acute Myeloid Leukemia With Del(5q) / Childhood Acute Myeloid Leukemia in Remission / Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable / Accelerated Phase Chronic Myelogenous Leukemia (CML) / Recurrent Childhood Acute Myeloid Leukemia / Adult Acute Myeloid Leukemia in Remission / Chronic Phase Chronic Myeloid Leukemia / Hematopoietic/Lymphoid Cancer / Chronic Myelogenous Leukemia (CML) in Blast Crisis / Adult Acute Myeloid Leukemia With T(15;17)(q22;q12) / Relapsing Chronic Myelogenous Leukemia / Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Treatment

Indications	Status	Purpose	Phase
DBCOND0029153 (Childhood Chronic Myelogenous Leukemia) DBCOND0153828 (previously treated Myelodysplastic Syndromes (MDS)) DBCOND0153442 (primary Myelodysplastic Syndromes (MDS)) DBCOND0036072 (Adult Acute Myeloid Leukemia With T(16;16)(p13;q22)) DBCOND0036073 (Adult Acute Myeloid Leukemia With T(8;21)(q22;q22)) DBCOND0028524 (Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities) DBCOND0028883 (Recurrent Adult Acute Myeloid Leukemia) DBCOND0028571 (Childhood Myelodysplastic Syndromes) DBCOND0028525 (Adult Acute Myeloid Leukemia With Del(5q)) DBCOND0028882 (Childhood Acute Myeloid Leukemia in Remission) DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable) DBCOND0121922 (Accelerated Phase Chronic Myelogenous Leukemia (CML)) DBCOND0028637 (Recurrent Childhood Acute Myeloid Leukemia) DBCOND0028881 (Adult Acute Myeloid Leukemia in Remission) DBCOND0057382 (Chronic Phase Chronic Myeloid Leukemia) DBCOND0030132 (Hematopoietic/Lymphoid Cancer) DBCOND0069499 (Chronic Myelogenous Leukemia (CML) in Blast Crisis) DBCOND0036071 (Adult Acute Myeloid Leukemia With T(15;17)(q22;q12)) DBCOND0028987 (Relapsing Chronic Myelogenous Leukemia) DBCOND0028526 (Adult Acute Myeloid Leukemia With Inv(16)(p13;q22))	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01056614	Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies	Antilymphocyte immunoglobulin (horse) (DB09312) Antithymocyte immunoglobulin (rabbit) (DB00098) Busulfan (DB01008) Fludarabine (DB01073) Methotrexate (DB00563) Tacrolimus (DB00864)